CDTX: Cidara Therapeutics Inc Company Profile & Statistics

About

Cidara Therapeutics, Inc. is a biotechnology company. The company is focused on the discovery, development and commercialization of novel anti-infectives. Its product pipeline includes CD101 IV, a long-acting echinocandin antifungal, CD101 topical and C001 which are in different clinical trial. The company developed its product using Cloudbreak(TM) immunotherapy platform. Cidara Therapeutics, Inc. is headquartered in San Diego, California.

Info & Links

CEO

Jeffrey Stein

Headquarters

6310 NANCY RIDGE DRIVE, SUITE 101
SAN DIEGO, CA 92121, UNITED STATES

Auditor

Ernst & Young LLP

Share holders

Employees

Cidara Therapeutics Inc Statistics

Valuation Measures

Market Capitalization²

163.77M

Enterprise Value

36.64M

Enterprise Value/EBITDA(ttm)

-0.26

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

4.06

Price to Book(mrq)

1.37

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

68.76%

Operating Margin(ttm)

-79.45%

Profit Margin(ttm)

-7583.66%

Return on Equity(ttm)

-69.64%

Return on Invested Capital(ttm)

167.04%

Return on Assets(ttm)

-33.73%

Income Statement

Revenue(ttm)

32.26M

Revenue Per Share(ttm)

4.58

Gross Profit(ttm)

29.17M

EBITDA(ttm)³

-139.70M

Net Income Available to Common(ttm)

-120.10M

Diluted EPS(ttm)

-25.52

Share Statistics

Beta (5Y Monthly)

1.13

52-Week Change

52.13%

S&P 500 52-Week Change

23.94%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

7.05M

Dividend Yield

0.00%

Float⁴

6.51M

% Held by Insiders

7.64%

% Held by Institutions

35.82%

Balance Sheet

Total Cash(mrq)

127.39M

Total Cash Per Share(mrq)

18.08

Total Debt(mrq)

259.00K

Total Debt/Equity(mrq)

0.22%

Current Ratio(mrq)

3.54%

Quick Ratio(mrq)

3.54%

Book Value Per Share(mrq)

16.41

Cash Flow

Operating Cash Flow Per Share(ytd)

-22.53

Free Cash Flow(ytd)

-147.25M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

CDTX

Cidara Therapeutics Inc

Cidara Therapeutics Inc Profile